PT1376136E - Processo para testar o efeito hormonal de substancias - Google Patents

Processo para testar o efeito hormonal de substancias

Info

Publication number
PT1376136E
PT1376136E PT03012914T PT03012914T PT1376136E PT 1376136 E PT1376136 E PT 1376136E PT 03012914 T PT03012914 T PT 03012914T PT 03012914 T PT03012914 T PT 03012914T PT 1376136 E PT1376136 E PT 1376136E
Authority
PT
Portugal
Prior art keywords
foxg1c
substances
testing
receptor
comodulator
Prior art date
Application number
PT03012914T
Other languages
English (en)
Inventor
Siegmund Wolf
Meyer Rene
Maik Obendorf
Jens Schroder
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT1376136E publication Critical patent/PT1376136E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Compounds Of Unknown Constitution (AREA)
PT03012914T 2002-06-12 2003-06-06 Processo para testar o efeito hormonal de substancias PT1376136E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10226674A DE10226674B4 (de) 2002-06-12 2002-06-12 Verfahren zur Testung des hormonellen Effekts von Substanzen

Publications (1)

Publication Number Publication Date
PT1376136E true PT1376136E (pt) 2006-07-31

Family

ID=27588642

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03012914T PT1376136E (pt) 2002-06-12 2003-06-06 Processo para testar o efeito hormonal de substancias

Country Status (9)

Country Link
US (1) US20040009524A1 (pt)
EP (1) EP1376136B1 (pt)
JP (1) JP2004016236A (pt)
AT (1) ATE320608T1 (pt)
DE (2) DE10226674B4 (pt)
DK (1) DK1376136T3 (pt)
ES (1) ES2260548T3 (pt)
NO (1) NO20032609D0 (pt)
PT (1) PT1376136E (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007536904A (ja) * 2003-11-03 2007-12-20 アカディア ファーマシューティカルズ，インコーポレーテッド ｒａｐ−ｒａｓキメラタンパク質を用いるＧタンパク質共役受容体の高スループット機能アッセイ
EP1812798A2 (en) * 2004-11-19 2007-08-01 Acadia Pharmaceuticals Inc. Enabling tools to identify ligands for hormone nuclear receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20021900L (no) * 2001-05-04 2002-11-05 Jenapharm Gmbh FremgangsmÕte for analyse av forbindelsers hormonvirkning

Also Published As

Publication number Publication date
EP1376136A2 (de) 2004-01-02
ES2260548T3 (es) 2006-11-01
DE10226674B4 (de) 2006-01-05
ATE320608T1 (de) 2006-04-15
JP2004016236A (ja) 2004-01-22
US20040009524A1 (en) 2004-01-15
DE50302644D1 (de) 2006-05-11
EP1376136B1 (de) 2006-03-15
DE10226674A1 (de) 2004-01-08
NO20032609D0 (no) 2003-06-10
EP1376136A3 (de) 2004-01-14
DK1376136T3 (da) 2006-07-10

Similar Documents

Publication Publication Date Title
Cervellati et al. Oxidative damage and the pathogenesis of menopause related disturbances and diseases
Yang et al. Neuronal release of proBDNF
Clark et al. Glucocorticoid modulation of tryptophan hydroxylase-2 protein in raphe nuclei and 5-hydroxytryptophan concentrations in frontal cortex of C57/Bl6 mice
BRPI0002963B8 (pt) processo e dispositivo medidor eletroquímico para medir uma concentração de analito em uma amostra.
BRPI0600875A (pt) método e sistema de inspeção empregando a análise multifrequencial da fase
UY29819A1 (es) Voltametria regulada
DE60106228D1 (de) Elektrochemischer biosensor-teststreifen mit erkennungselektrode und auslesemessgerät, das diesen teststreifen verwendet
Raudensky et al. Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function
Schwab et al. Free epinephrine, norepinephrine and dopamine in saliva and plasma of healthy adults.
Wikström Glucocorticoid action and novel mechanisms of steroid resistance: role of glucocorticoid receptor-interacting proteins for glucocorticoid responsiveness.
ATE438098T1 (de) Teststreifen enthaltend kontrollmittel und zeitsetzermittel
PT1376136E (pt) Processo para testar o efeito hormonal de substancias
TR200402024T4 (tr) Maddelerin hormon etkisini test yöntemi
Pelkonen et al. Stimulated dopamine overflow and alpha‐synuclein expression in the nucleus accumbens core distinguish rats bred for differential ethanol preference
O'Brien et al. Measuring d‐serine efflux from mouse cortical brain slices using online microdialysis‐capillary electrophoresis
DE50300480D1 (de) Verfahren zur Testung des hormonellen Effekts von Substanzen
Nitsch et al. Regulation of proteolytic processing of the amyloid beta-protein precursor by first messengers. A novel potential approach for the treatment of Alzheimer's disease.
Galazzo et al. Changes in the fraction of strongly attached cross bridges in mouse atrophic and hypertrophic muscles as revealed by continuous wave electron paramagnetic resonance
Aluf et al. Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule
Kim et al. Matrix metalloproteinase-3 contributes to vulnerability of the nigral dopaminergic neurons
Kita et al. New perspectives on the mechanism of methamphetamine-induced neurotoxicity
Vulcu et al. Proton conductance of human transient receptor potential–vanilloid type-1 expressed in oocytes of Xenopus laevis and in Chinese hamster ovary cells
ATE343795T1 (de) Verfahren zur bestimmung des hormonellen effekts von substanzen mittels der interaktion zwischen dem androgenrezeptor und ewing sarkoma protein.
ATE510206T1 (de) Testkit
ITMI20022011A1 (it) Metodo e sistema per la misura della concentrazione di ossigeno e acqua in idrogeno mediante spettroscopia do mobilita' ionica.